FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10132311000001109: Drotrecogin alfa 20mg powder for solution for injection vials 1 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
32240101000001117 Drotrecogin alfa 20mg powder for solution for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52721001000001114 Drotrecogin alfa 20mg powder for solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Is pack of Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has active ingredient Substance with enzyme mechanism of action false Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has active ingredient Drotrecogin alfa false Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has active ingredient Drotrecogin alfa activated false Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has VMP Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has specific active ingredient Drotrecogin alfa true Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Xigris 20mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial Is a True Drotrecogin alfa 20mg powder for solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start